Modulation of the estrogen/erbB2 receptors crosstalk by CDK4/6 inhibition triggers sustained senescence in estrogen receptor and erbB2 positive breast cancerModulation of the ER/HER2 crosstalk by CDK4/6 inhibition
Article in Clinical Cancer Research (March 2022)